Abstract: In some embodiments, techniques for using machine learning to enable visible light pupilometry are provided. In some embodiments, a smartphone may be used to create a visible light video recording of a pupillary light reflex (PLR). A machine learning model may be used to detect a size of a pupil in the video recording over time, and the size over time may be presented to a clinician. In some embodiments, a system that includes a smartphone and a box that holds the smartphone in a predetermined relationship to a subject's face is provided. In some embodiments, a sequential convolutional neural network architecture is used. In some embodiments, a fully convolutional neural network architecture is used.
Type:
Application
Filed:
March 20, 2023
Publication date:
July 20, 2023
Applicant:
University of Washington
Inventors:
Lynn B. McGrath, Anthony Law, Randall Bly, Shwetak N. Patel, Alex T. Mariakakis, Jacob Baudin
Abstract: Polymers, monomers, chromophoric polymer dots and related methods are provided. Highly fluorescent chromophoric polymer dots with narrow-band emissions are provided. Methods for synthesizing the chromophoric polymers, preparation methods for forming the chromophoric polymer dots, and biological applications using the unique properties of narrow-band emissions are also provided.
Type:
Grant
Filed:
September 21, 2018
Date of Patent:
July 11, 2023
Assignee:
University of Washington through its Center for Commercialization
Inventors:
Daniel T. Chiu, Changfeng Wu, Yu Rong, Yong Zhang, Yi-Che Wu, Yang-Hsiang Chan, Xuanjun Zhang, Jiangbo Yu, Wei Sun
Abstract: An eye-tracking system, including at least one vertical capacitance sensor, configured to measure the vertical position of a cornea of a user's eye by sensing a position of an eyelid of the user; and at least one horizontal capacitance sensor, configured to measure the horizontal position of the cornea of the user's eye by sensing a position of the user's eyeball.
Abstract: Cell-separation systems and methods utilizing cell-specific microbubble tags and ultrasound-based separation are described. The methods are useful for simplification of time-consuming and costly cell purification procedures and real time apoptosis detection.
Type:
Grant
Filed:
June 27, 2019
Date of Patent:
July 11, 2023
Assignee:
University of Washington
Inventors:
Thomas J. Matula, Masaoki Kawasumi, Oleg Sapozhnikov
Abstract: A capacitive sensor including an electrically conductive material, and a single electrode applied with positive potential, wherein the distance between the single electrode and the electrically conductive material determines the spherical radius for a proximity sensing range.
Abstract: Methods for inhibiting or treating viral infection in a subject infected with a vims of the arenaviridae family with a therapeutic agent combination: (a) arbidol and aripiprazole; (b) arbidol and amodiaquine; (c) arbidol and sertraline; (d) arbidol, iprazole, and amodiaquine; (e) arbidol, aripiprazole, and sertraline; or (f) aripiprazole and amodiaquine; or pharmaceutically acceptable salts thereof.
Type:
Application
Filed:
May 24, 2021
Publication date:
July 6, 2023
Applicants:
UNIVERSITY OF WASHINGTON, UNIVERSITY OF VIRGINIA PATENT FOUNDATION
Inventors:
Stephen J. Polyak, Shawn Herring, Jessica Wagoner, Judith White
Abstract: Computational methods used for large scale scaffolding of a genome assembly are provided. Such methods may include a step of applying a location clustering model to a test set of contigs to form two or more location cluster groups, each location cluster group comprising one or more location-clustered contigs; a step of applying an ordering model to each of the two or more location cluster groups to form an ordered set of one or more location-clustered contigs within each cluster group; and a step of applying an orienting model to each ordered set of one or more location-clustered contigs to assign a relative orientation to each of the location-clustered contigs within each location cluster group. In some aspects, the test set of contigs are generated from aligning a set of reads generated by a chromosome conformation analysis technique (e.g., Hi-C) with a draft assembly, a reference assembly, or both.
Type:
Grant
Filed:
September 27, 2014
Date of Patent:
July 4, 2023
Assignee:
UNIVERSITY OF WASHINGTON
Inventors:
Jay Shendure, Andrew Adey, Joshua Burton, Jacob Kitzman, Maitreya J. Dunham, Ivan Liachko
Abstract: Provided are compositions and methods for the production of modified endonucleases such as CRISPR/Cas9 system with reduced off-target activity. Methods of editing of polynucleotides using the modified endonucleases in vitro and in vivo are also disclosed. In one aspect, the disclosure provides a modified endonuclease, comprising an endonuclease and one or more mixed charge moieties covalently linked to the endonuclease, wherein each mixed charge moiety comprises about 10 to about 400 positively charged moieties and about 10 to about 400 negatively charged moieties, and wherein the ratio of the number of positively charged moieties to the number of negatively charged moieties is from about 1 :0.5 to about 1 :2.
Abstract: Methods for inducing cell death by magneto-endosomalytic therapy using magnetic nano articles. The methods include inducing cell death, inducing cell death in a subject, and application of the methods to killing tumor cells in a subject.
Abstract: Fluidic device and methods of preparing a fibrous pad comprising dried reagents deposited thereon are described. In an embodiment, the fluidic devices comprise a fibrous pad; and a lyophilized reagent depot configured to support nucleic amplification of a target nucleic acid molecule to produce amplicons when dissolved, wherein the lyophilized reagent depot is disposed on the fibrous pad, the lyophilized reagent depot comprising: a nucleic acid amplification enzyme configured to perform a nucleic acid amplification reaction producing amplicons; and a lyophilization agent.
Abstract: Reagents, methods, and kits for assaying enzymes associated with lysosomal storage diseases MPS-I, MPS-II, MPS-IIIA, MPS-IIIB, MPS-IVA, MPS-VI, and MPS VII.
Type:
Application
Filed:
February 22, 2023
Publication date:
June 29, 2023
Applicant:
University of Washington through its Center for Commercialization
Inventors:
Michael H. Gelb, Arun Babu Kumar, Frances Hocutt, Zdenek Spacil, Mariana Natali Barcenas Rodriguez, Frantisek Turecek, C. Ronald Scott
Abstract: Apparatus and method for photo-chemical oxidation are disclosed herein. In one embodiment, a system for treating a dialysis fluid includes: a nanostructured photo-electrochemical anode; a source of light configured to illuminate the photo-electrochemical anode; and a cathode that is permeable to oxygen provided to the dialysis fluid and non-permeable to a liquid of the dialysis fluid. The photo-electrochemical anode is configured to remove urea from the dialysis fluid by converting the urea in the dialysis fluid into oxidation products through a photo electrochemical reaction.
Abstract: Methods of uniquely labeling or barcoding molecules within a cell, a plurality of cells, and/or a tissue are provided. Kits for uniquely labeling or barcoding molecules within a cell, a plurality of cells, and/or a tissue are also provided. The molecules to be labeled may include, but are not limited to, RNAs, cDNAs, DNAs, proteins, peptides, and/or antigens.
Type:
Application
Filed:
July 25, 2022
Publication date:
June 22, 2023
Applicant:
University of Washington
Inventors:
Georg Seelig, Richard Muscat, Alexander B. Rosenberg
Abstract: Methods of uniquely labeling or barcoding molecules within a nucleus, a plurality of nuclei, a cell, a plurality of cells, and/or a tissue are provided. Kits for uniquely labeling or barcoding molecules within a nucleus, a plurality of nuclei, a cell, a plurality of cells, and/or a tissue are also provided. The molecules to be labeled may include, but are not limited to, RNAs and/or cDNAs.
Type:
Grant
Filed:
September 21, 2018
Date of Patent:
June 20, 2023
Assignee:
UNIVERSITY OF WASHINGTON
Inventors:
Georg Seelig, Alexander B. Rosenberg, Charles Roco
Abstract: The present disclosure provides encoded chromophoric polymer particles that are capable of, for example, optical and/or biomolecular encoding of analytes. The present disclosure also provides suspensions comprising a plurality of encoded chromophoric polymer particles. The present disclosure also provides methods of using the encoded chromophoric polymer particles and systems for performing multiplex analysis with encoded chromophoric polymer particles.
Type:
Grant
Filed:
November 30, 2021
Date of Patent:
June 13, 2023
Assignee:
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Inventors:
Daniel T. Chiu, Changfeng Wu, Jiangbo Yu
Abstract: The present disclosure features a composition, including molecularly imprinted crosslinked polymers that have been imprinted with trimethylamine N-oxide. The molecularly imprinted crosslinked polymers have specific binding sites for trimethylamine N-oxide, and a trimethylamine N-oxide absorption capacity of at least 0.5 mg/g.
Abstract: A method for predicting if a flow over a smooth ramp surface will separate from the ramp surface, wherein the ramp surface has a slope that is everywhere non-positive along the length of the ramp surface relative to the flow at the inflow end of the ramp surface includes i) dividing the height of the ramp surface by the length of the ramp surface to determine a height-to-length ratio of the ramp surface, ii) identifying a maximum slope magnitude of the ramp surface, iii) calculating a maximum normalized slope by dividing the maximum slope magnitude of the ramp surface by the height-to-length ratio of the ramp surface, and calculating a critical ramp slope as a linear function of the height-to-length ratio of the ramp surface. If the maximum normalized slope is greater than the critical ramp slope, the method predicts the turbulent boundary layer will separate from the ramp surface.
Type:
Application
Filed:
May 18, 2021
Publication date:
June 8, 2023
Applicant:
UNIVERSITY OF WASHINGTON
Inventors:
Antonino Ferrante, Abhiram Aithal, Dawei Lu
Abstract: Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundreds of millions of sequencing mistakes. These scattered errors can be tolerated in some applications but become extremely problematic when “deep sequencing” genetically heterogeneous mixtures, such as tumors or mixed microbial populations. To overcome limitations in sequencing accuracy, a method Duplex Consensus Sequencing (DCS) is provided. This approach greatly reduces errors by independently tagging and sequencing each of the two strands of a DNA duplex. As the two strands are complementary, true mutations are found at the same position in both strands. In contrast, PCR or sequencing errors will result in errors in only one strand.
Type:
Grant
Filed:
August 2, 2021
Date of Patent:
June 6, 2023
Assignee:
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Inventors:
Jesse Salk, Lawrence A. Loeb, Michael Schmitt
Abstract: Methods and systems for improved labeling and/or de-labeling a molecule or cell in the context of scientific experimentation, industrial applications, and clinical investigation, including the means to repeat the process of labeling and de-labeling in an efficient manner.
Abstract: Systems and methods for detecting a target moiety are disclosed. A system includes a substrate holder including a porous matrix. The porous matrix includes a first detectable agent and a second detectable agent. The system includes a housing, optically coupled with the substrate holder, and shaped to optically couple with a radiation source and a radiation sensor and to optically isolate the radiation source and the radiation sensor. The system includes an excitation filter, disposed in or on the housing, configured to receive excitation electromagnetic radiation from the radiation source and to transmit a first portion of the excitation electromagnetic radiation to the porous matrix. The system also includes an emission filter, disposed in or on the housing, configured to receive emitted fluorescence electromagnetic radiation from the porous matrix and to transmit a second portion of the emitted fluorescence electromagnetic radiation, the second portion being different from the first portion.